CERVIVA
Published on CERVIVA (http://cerviva.ie)

Home > Scientific papers

Scientific papers

2016

  • Exploring women's sensory experiences of undergoing colposcopy and related procedures: implications for preparatory sensory information provision
    O'Connor M, Waller J, Gallagher P, Martin CM, JO'Leary J, D'Arcy T, Prendiville W, Flannelly G, Sharp L.
  • Triage of LSIL/ASC-US with p16/Ki-67 dual staining and human papillomavirus testing: a 2-year prospective study
    White C, Bakhiet S, Bates M, Keegan H, Pilkington L, Ruttle C, Sharp L, O' Toole S, Fitzpatrick M, Flannelly G, O' Leary JJ, Martin CM

2015

  • Beware of Kinked Frontiers: A Systematic Review of the Choice of Comparator Strategies in Cost-Effectiveness Analyses of Human Papillomavirus Testing in Cervical Screening
    O'Mahony JF, Naber SK, Normand C, Sharp L, O'Leary JJ, de Kok IM
  • Trends in, and predictors of, anxiety and specific worries following colposcopy: a 12-month longitudinal study
    O'Connor M, O'Leary E, Waller J, Gallagher P, D'arcy T, Flannelly G, Martin CM, McRae J, Prendiville W, Ruttle C, White C, Pilkington L, O'Leary JJ, Sharp L; Irish Cervical Screening Research Consortium (CERVIVA)
  • Understanding Women's Differing Experiences of Distress after Colposcopy: A Qualitative Interview Study
    O'Connor M, Waller J, Gallagher P, Martin CM, O'Leary JJ, D'Arcy T, Prendiville W, Flannelly G, Sharp L; Irish Screening Research Consortium (CERVIVA)
  • Human papillomavirus prevalence and type-distribution in cervical glandular neoplasias: Results from a European multinational epidemiological study
    Holl K, Nowakowski AM, Powell N, McCluggage WG, Pirog EC, Collas De Souza S, Tjalma WA, Rosenlund M, Fiander A, Castro Sánchez, Damaskou V, Joura EA, Kirschner B, Koiss R, O'Leary J, Quint W, Reich O, Torné A, Wells M, Rob L Kolomiets L, Molijn A, et al.
  • Adverse psychological outcomes following colposcopy and related procedures: a systematic review
    O'Connor M, Gallagher P, Waller J, Martin CM, O'Leary JJ, Sharp L
  • Dealing with Time in Health Economic Evaluation: Methodological Issues and Recommendations for Practice
    O'Mahony JF, Newall AT, van Rosmalen J
  • The Use of MYBL2 as a Novel Candidate Biomarker of Cervical Cancer
    Martin CM, Astbury K, Kehoe L, O'Crowley JB, O'Toole S, O'Leary JJ

2014

  • Raman microspectroscopy for the early detection of pre-malignant changes in cervical tissue
    Rashid N, Nawaz H, Poon KW, Bonnier F, Bakhiet S, Martin C, O'Leary JJ, Byrne HJ, Lyng FM
  • 'I don't care whether it's HPV or ABC, I just want to know if I have cancer' Factors influencing women's emotional responses to undergoing human papillomavirus testing in routine management in cervical screening: a qualitative study
    O'Connor M, Costello L, Murphy J, Prendiville W, Martin CM, O'Leary JJ, Sharp L; Irish Screening Research Consortium (CERVIVA)
  • Influences on human papillomavirus (HPV)-related information needs among women having HPV tests for follow-up of abnormal cervical cytology
    O'Connor M, Costello L, Murphy J, Prendiville W, Martin CM, O'Leary JJ, Sharp L; On behalf of the Irish Screening Research Consortium (CERVIVA)
  • Human papillomavirus DNA and mRNA prevalence and association with cervical cytological abnormalities in the Irish HIV population
    Loy A, McInerney J, Pilkington L, Keegan H, Delamere S, Martin CM, Sheils O, O'Leary JJ, Mulcahy F
  • Motivators for women to attend cervical screening: the influential role of GPs
    O'Connor M, Murphy J, Martin C, O'Leary J, Sharp L; Irish Cervical Screening Consortium (CERVIVA)
  • Role of human papillomavirus in oropharyngeal squamous cell carcinoma: A review
    Woods R Sr, O'Regan EM, Kennedy S, Martin C, O'Leary JJ, Timon C
  • Human papillomavirus detection and genotyping, by HC2, full-spectrum HPV and molecular beacon real-time HPV assay in an Irish colposcopy clinic
    Keegan H, Pilkington L, McInerney J, Jeney C, Benczik M, Cleary S, von Bunau G, Turner M, D'Arcy T, O' Toole S, Pal-Szenthe B, Kaltenecker B, Mózes J, Kovács A, Solt A, Bolger N, O'Leary J, Martin C
  • "If you can't treat HPV, why test for it?" Women's attitudes to the changing face of cervical cancer prevention: a focus group study
    McRae J, Martin C, O'Leary J, Sharp L; Irish Cervical Screening Research Consortium (CERVIVA)
  • The Influence of Disease Risk on the Optimal Time Interval between Screens for the Early Detection of Cancer A Mathematical Approach
    O’Mahony, JF, van Rosmalen, J, Mushkudiani, NA, Goudsmit, F-W, Eijkemans, MJ, Heijnsdijk, EA, Steyerberg E & Habbema, JDF
  • Processing ThinPrep Cervical Cytological Samples for Raman Spectroscopic Analysis
    Bonnier, FM, Traynor, D, Kearney, P, Clarke, C, Knief, P, Martin, C, O’Leary, JJ, Byrne, HJ, Lyng, FM

2013

  • Evaluation of the clinical performance of the cobas 4800 HPV test in patients referred for colposcopy
    White C, Keegan H, Pilkington L, Ruttle C, Kerr P, Sharp L, O'Toole S, Turner M, Prendiville W, D'Arcy T, Fitzpatrick M, Lenehan P, Flannelly G, O'Leary JJ, Martin CM

Pages

  • 1
  • 2
  • 3
  • next ›
  • last »

Copyright © Cerviva 2015. Developed by Mark.


Source URL (retrieved on 2017-10-30 18:24): http://cerviva.ie/publications/scientific-papers